Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    24175720 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine Fumarate Sustained Release
2 Completed Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine fumarate
3 Completed Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine fumarate
4 Completed
Has Results
Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine
5 Completed Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Quetiapine fumarate;   Drug: Duloxetine
6 Completed Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Quetiapine SR;   Drug: Escitalopram

Indicates status has not been verified in more than two years